Cosmetic dermatology marketing agency for US practices — physician-led medical-grade positioning, HIPAA-safe, 50-state board-compliant
Ichelon Global is a cosmetic dermatology marketing agency headquartered in Dallas, Texas, running cash-pay patient acquisition for US physician-led cosmetic dermatology practices across all 50 states. Cosmetic dermatology sits above med spa and below plastic surgery on the aesthetic authority ladder — a licensed dermatologist personally leading a catalogue of injectables, laser resurfacing, chemical peels, PDO threads, radiofrequency microneedling and prescription cosmeceuticals. That positioning wins on trust, but only if the marketing carries it into the funnel. Every campaign is scoped inside a HIPAA + TCPA + FTC + FDA + state medical board envelope.
Backed by App\Support\NamedExperts::get(). --}}
- Ichelon Global is a Dallas-headquartered cosmetic dermatology marketing agency serving US practices — from solo cosmetic dermatologists to multi-state cosmetic derm groups embedded inside larger dermatology platforms — across Texas, California, Florida, New York, Georgia, Arizona, Tennessee, Illinois, Washington and every other state where a licensed dermatologist can advertise.
- Every engagement is scoped against HIPAA (OCR 2022/2024 tracking bulletin), TCPA (2024 FCC revocation updates), CAN-SPAM, ADA, FTC 16 CFR §255 Endorsement Guides, FDA 21 CFR §202.1 on prescription drug advertising, Meta Personal Attributes policy, and each state's medical board rules on physician advertising.
- Retainers are custom-scoped per practice, typically $2,500 to $8,000 per month. Cash-pay cosmetic derm consult CPQL runs $75 to $220 depending on metro tier and treatment mix, with laser and body work sitting at the top of that band and injectable-only intent at the bottom.
- Delivery stack covers organic search, Google Ads, Meta Ads, GBP density across every clinical address, YouTube dermatologist-authority (YODA), reputation cross-monitoring including RealSelf, cosmeceutical-line commerce where applicable, and CRM attribution back to booked and completed consults.
A marketing agency that treats cosmetic dermatology as its own vertical — not as an add-on to a medical derm plan
Cosmetic dermatology is a specific commercial reality inside US medicine. It is not medical dermatology with an aesthetic bolt-on. It is not med spa either — the buyer expects a physician in the room and prices accordingly. Cosmetic dermatology is a cash-pay medical practice led by a board-certified dermatologist personally performing a catalogue of injectables, laser resurfacing, IPL, chemical peels, radiofrequency microneedling, threads, biostimulators (Sculptra, Radiesse), fat reduction (CoolSculpting, EmSculpt Neo), and prescription-strength cosmeceutical regimens. It occupies a specific position on the aesthetic-authority ladder — above med spa on physician credibility, below plastic surgery on invasive intervention — and its buyer comes looking for exactly that positioning.
A generic dermatology marketing plan that runs a single site architecture for both medical and cosmetic dermatology will underperform on both. Medical dermatology intent is symptom-led, insurance-verified, and referral-driven; cosmetic dermatology intent is aspiration-led, cash-pay, and social-driven. Trying to rank the same URL for "acne dermatologist near me" and "Botox dermatologist near me" splits the topical authority in ways Google's core update cycle has punished repeatedly since 2022. Ichelon Global builds cosmetic dermatology as a separate topic map — its own site section (or its own subdomain / satellite site depending on the practice's structure), its own paid campaigns, its own creative library, its own GBP category treatment, and its own reputation surface.
Our Dallas HQ at 3714 Matador Dr sits in the Central time zone where most US cosmetic dermatology operators run leadership calls, and Santosh Reddy leads our US practice from that address. Texas is the second-largest US dermatology market by practice count and one of the top three cosmetic dermatology cash-pay markets. The DFW corridor concentrates the largest cluster of physician-led cosmetic dermatology practices in the state, and Texas Medical Board Rule 165.5 governs the advertising standard that most other Southern and Midwestern states then benchmark to.
But the Dallas address anchors the delivery pod, not client geography. We currently run active engagements across Texas, California, Florida, New York, Georgia, Arizona, Tennessee, Illinois and Washington, and we scope net-new engagements in any state where a licensed dermatologist can advertise cosmetic services. Multi-state cosmetic dermatology groups get a single national delivery pod with per-state creative review, per-state paid-media benchmarks, per-state supervising-physician review workflows, and a consolidated national SEO topic map that treats the physician's cosmetic authority as the sitewide anchor.
The cosmetic dermatology catalogue — every service is its own marketing sub-motion
A cosmetic dermatology practice runs a broader catalogue than most operators realise until they map it out for SEO. Each service line has its own buyer intent, its own paid-media pricing, its own compliance posture on the FDA on-label / off-label boundary, and its own retention pattern. Treating them as one bucket for marketing purposes is the biggest single reason cosmetic derm campaigns underperform their potential. We build the topic map per line.
Neurotoxin injectables (Botox, Dysport, Xeomin, Jeuveau, Daxxify)
The volume anchor of most cosmetic derm practices. FDA on-label indications vary by brand and by treatment area, so the creative has to be tuned to each product's approved indication. Manufacturer rewards (Allergan Alle, Galderma ASPIRE Rewards, Merz Xperience+) route repeat purchase and should be integrated into the acquisition funnel.
Dermal filler (Juvederm, Restylane, RHA, Belotero, Versa)
Higher ticket than neurotoxin, longer buyer research window, and more visually-led creative demand. Site content has to hold both anatomical-area topics (lip filler, cheek filler, chin filler, tear trough filler) and product-brand topics without triggering FDA fair-balance flags. Before/after imagery scoped to state medical board consent rules on every asset.
Biostimulators (Sculptra, Radiesse)
The fastest-growing sub-category in physician-led cosmetic derm — collagen-stimulating products that sit between filler and regenerative aesthetic. Higher ticket, longer treatment series, and a buyer who researches at length before booking. Marketing has to hold a longer education arc and route the trust-build through the dermatologist as the clinical authority.
Laser and energy-based devices
Fraxel, Halo, BBL, Clear + Brilliant, Fraxel Dual, IPL, PicoSure Pro, CoolPeel — each with its own indication and its own buyer-research pattern. Body devices (EmSculpt Neo, CoolSculpting Elite, EmTone, Sofwave, Ultherapy) sit as a separate cluster. Ticket is materially higher than injectable, so buyer window is longer and creative depth has to earn that consideration.
Chemical peels and resurfacing
The workhorse of dermatologist-led cash-pay practice — Vitalize, VI Peel, TCA, Perfect Derma, Cosmelan. Buyer intent is more search-driven and less social-driven than injectables. Content depth on ingredients, skin type, and downtime is what wins the ranking here.
Threads, microneedling and hybrid procedures
PDO threads, radiofrequency microneedling (Morpheus8, Genius RF, Vivace, Secret RF), microneedling with PRP or exosomes, and hybrid protocols combining multiple modalities. Emerging categories where the physician's clinical authority matters most because buyer research is thin — and where cosmetic derm practices win share against med spas that cannot legally offer the same combinations.
Prescription cosmeceuticals and skincare
Tretinoin, hydroquinone, brand cosmeceutical lines (SkinCeuticals, Alastin, ZO Skin Health, Obagi, EltaMD, Skinbetter). Some practices run this as a full commerce line; others as an in-office regimen sale. The marketing motion is different for each — commerce-led practices need ecommerce SEO overlaid on the medical site, while regimen-led practices need education content that pulls the buyer into the visit.
Body contouring and skin tightening
CoolSculpting Elite, EmSculpt Neo, Sofwave, Ultherapy, EmTone. Higher ticket, longer research window, and stronger before/after visual expectations. Post-GLP-1 loose-skin demand has materially expanded this category since 2023. Marketing has to hold the clinical framing without slipping into weight-loss language subject to Meta Personal Attributes rejection.
The US cosmetic dermatology market — the numbers behind the strategy
A national cosmetic dermatology marketing plan has to start from the actual size and shape of the market. The underlying data:
The US dermatology practice count spans 13,774 clinical locations. Not every one runs a serious cosmetic dermatology practice — our internal estimate is that roughly 55 to 65 percent of US dermatology practices offer at least neurotoxin and filler, and roughly 25 to 35 percent run cosmetic dermatology as a meaningful revenue line with dedicated aesthetic staff, dedicated treatment rooms, and dedicated marketing. That subset — call it 3,500 to 4,800 practices — is where the cash-pay cosmetic dermatology market actually lives. It is a smaller pool than the med spa count (10,488) but with materially higher per-visit revenue and materially higher LTV per acquired buyer.
Five state-level realities shape a US cosmetic dermatology marketing plan today:
- California is the #1 US dermatology market by practice count with 1,743 practices (roughly 12.6% of the national footprint). Cosmetic dermatology in California concentrates in Los Angeles, San Francisco, San Diego, Orange County and the Bay Area's East Bay expansion. California's cosmetic buyer density, its Bus & Prof Code §17500 truthful-advertising rules, and its Medical Board §2261 supervision structure combine to make it the most rewarding — and most compliance-heavy — state to compete in.
- Texas is the second-largest US dermatology market and one of the top three cosmetic dermatology states. Roughly 1,180 dermatology practices, weighted heavily to Dallas-Fort Worth, Houston, Austin and San Antonio. Texas Medical Board Rule 165.5 governs testimonials and before/after photography across the whole state, and the DFW aesthetic corridor concentrates a disproportionate share of cash-pay cosmetic dermatology revenue in the state.
- Florida is the third-largest cosmetic dermatology cash-pay market. Miami, Fort Lauderdale, Palm Beach, Tampa and Orlando anchor the state's cosmetic derm economy. Florida Statute 458.351 governs physician advertising, and the market skews strongly to injectables, laser resurfacing, and post-weight-loss skin-tightening. The Miami cosmetic dermatology buyer is arguably the most sophisticated in the country.
- New York cosmetic dermatology concentrates around Manhattan and Long Island. New York Education Law §6530 governs physician advertising and is enforced tightly on superlative claim substantiation. Manhattan cosmetic derm ticket is at or above Beverly Hills on most injectable and laser categories.
- Scottsdale, Nashville and Atlanta are the rising cohort. These three metros grew cosmetic dermatology density fastest between 2020 and 2025. Scottsdale in particular concentrates the highest aesthetic-buyer-per-capita in the country by most measures.
The top-demand US cosmetic dermatology markets by paid-media auction pressure and organic search competitiveness are Manhattan, Beverly Hills, Miami, Scottsdale, Dallas and Nashville. A national cosmetic derm plan that budgets to a US-wide average CPC will overspend in mid-tier metros and underspend in the top six — which is where a specialist agency earns its fee by moving media budget to metros where a $180 CPC still returns a positive consult LTV, and away from metros where a lower-nominal CPC still fails to convert.
State medical board rules on cosmetic dermatology advertising — the 50-state compliance matrix
Every US cosmetic dermatology practice advertises under two layers of medical board rules: the federal envelope described below, and the individual state medical board that issued the dermatologist's licence. Below is the condensed 50-state matrix Ichelon Global works from. This is the operating map, not a legal opinion — every practice's specific facts should be reviewed by its own healthcare counsel before creative deployment.
| State | Governing rule / statute | Key stance on cosmetic dermatology advertising |
|---|---|---|
| Texas | TMB Rule 165.5 & 165.1 | Written patient consent required for every testimonial and before/after image; no false, deceptive or misleading claims; superiority claims require verifiable methodology; injectable off-label discussion scrutinised. |
| Florida | Florida Statute 458.351 | Ban on deceptive advertising, mandatory disclosure of physician's medical qualifications, licensed name required in ads, before/after imagery must reflect typical results, injectable and laser claims tightly scrutinised. |
| California | CA Bus & Prof Code §17500 + Medical Board §2261 | Broadest truthful-advertising rule in the US; no misleading testimonials; disclosure of non-typical before/after results; strict on "board certified" claims for dermatology and cosmetic dermatology; Medical Corporation entity rules apply. |
| New York | NY Education Law §6530 | Professional misconduct rules cover any false, fraudulent or deceptive advertising by a licensed physician; strong on superiority claim substantiation; scrutiny on injectable and laser claims. |
| Georgia | GA Code §43-34-8 | Requires truthful, current-standard-of-care representation of results; no comparative superiority without objective basis; supervising physician disclosure required on dermatology cosmetic advertising. |
| Arizona | AZ Rev Stat §32-1454 | Testimonials must be honest and current; before/after must not misrepresent typical outcome; strict on injectable off-label promotion; Scottsdale market gets frequent enforcement attention on cosmetic advertising. |
| Tennessee | TN Code §63-6-214 | Deceptive advertising is unprofessional conduct; testimonials without disclosure of compensation prohibited; Nashville cosmetic derm practices watched closely on before/after claim language. |
| Illinois | IL Medical Practice Act §225 ILCS 60 | Strict on advertising outcomes as guarantees; before/after images require typical-results disclaimer where applicable; corporate practice of medicine rules shape entity-level advertising. |
| Washington | WA Medical Practice Act RCW 18.71 | Broad prohibition on false, fraudulent, misleading or deceptive statements in advertising; scope of practice by non-physician staff must not be overstated in cosmetic derm ads. |
| Pennsylvania | 49 Pa Code §16.61 | Bans deceptive statements, requires substantiation of claims, physician-name attribution required, before/after imagery must be current and reflect typical results. |
| All other states | State-specific board rules apply | Every remaining state has a materially similar deceptive-advertising prohibition. Ichelon Global scopes creative against the actual current rule and interpretive guidance of the state your dermatologist is licensed in. |
For multi-state cosmetic dermatology groups, we maintain a per-state creative review checklist that runs against every campaign asset — website copy, paid creative, GBP posts, Instagram carousels, YouTube titles, review-response templates, cosmeceutical ecommerce pages — before it goes live in that state. A single national creative that reads clean in Texas can trigger a Florida deceptive-advertising complaint if the results language is not appropriately hedged for the Florida Statute 458.351 standard. The cost of that mistake is not the creative rework — it is the board complaint, the licensure defence, and the reputational surface area that follows.
HIPAA, TCPA, CAN-SPAM, ADA, FTC, FDA — the federal envelope every cosmetic dermatology campaign runs inside
Above the state medical board layer sits a federal envelope that applies uniformly across all 50 states. A US cosmetic dermatology marketing plan that does not scope against every framework below is not a plan — it is an exposure profile the practice will carry until its first regulator complaint.
HIPAA (OCR 2022/2024 tracking bulletin)
Condition, service or provider information passed to a third-party analytics or ad platform can constitute PHI when tied to an individual identifier. Every cosmetic derm engagement starts with a PHI scrub across GA4, Google Ads conversions, Meta CAPI, TikTok Events API, Clarity, Hotjar, LiveChat and every third-party embed on the practice website. BAA-ready with every partner that requires one.
TCPA (2024 FCC revocation updates)
$500 to $1,500 statutory damages per violating message. Every lead-form disclosure, appointment-reminder SMS, injectable-reminder cadence, and reactivation outreach is audited against the current TCPA rule set including 2024 revocation-of-consent updates.
CAN-SPAM Act
Every US cosmetic derm email marketing program — event invites, seasonal promotions, cosmeceutical restock reminders, injectable reminders — is scoped for accurate sender identification, honest subject lines, physical postal address disclosure, and functioning one-click unsubscribe.
ADA (web accessibility)
Cosmetic dermatology websites are Title III places of public accommodation. WCAG 2.1 AA is the operative accessibility floor. We audit new-build and legacy sites against WCAG 2.1 AA (contrast, alt text, keyboard navigation, ARIA labelling) as part of engagement onboarding.
FTC 16 CFR §255 (Endorsement Guides)
Any influencer collaboration, patient advocate story, or incentivised Google review triggers the FTC Endorsement Guides. Material connection disclosure, honest depiction of results, and truthful representation of the endorser's actual experience are all in scope. We do not run influencer or review-incentive programs without an FTC-compliant disclosure structure built in.
FDA 21 CFR §202.1 (prescription drug advertising)
Any promotional communication that mentions Botox, filler brands, prescription cosmeceuticals (tretinoin, hydroquinone), or the on-label vs off-label boundary is subject to FDA prescription drug advertising rules. Fair balance, indication accuracy, and risk information disclosure are scoped into every relevant creative asset before publication.
Meta Personal Attributes policy
Meta's ad-review system rejects creative that implies knowledge of a person's medical condition, appearance or health status. Cosmetic derm creative that reads clean to a human reviewer can trigger a Personal Attributes rejection at scale. We rewrite creative pre-flight against the current Meta policy interpretation and monitor account-level policy risk continuously.
Google Healthcare and Medicines policy
Google Ads restricts prescription-drug promotion, applies personalisation restrictions to health-related audiences, and requires specific policy classification for certain aesthetic categories. Every US cosmetic derm Google Ads engagement is set up under the correct policy classification from account creation.
What the monthly stack actually delivers for a US cosmetic dermatology practice
Every cosmetic derm engagement runs on the same six delivery layers, weighted per practice. A solo cosmetic dermatologist in Beverly Hills weights heavier on paid social, RealSelf, and Instagram; a five-location cosmetic derm arm of a bigger dermatology group in Texas weights heavier on GBP density and organic search; a multi-state cosmetic derm platform weights heavier on per-location P&L attribution and cosmeceutical commerce.
1. SEO — cosmetic catalogue + dermatologist-provider clusters
Full cosmetic catalogue topic map (injectables by product and area, laser by device and indication, chemical peels by depth and skin type, biostimulators, threads, microneedling, body contouring, cosmeceuticals) tied to cash-pay intent. Dermatologist-provider cluster built around each cosmetic dermatologist as the authority anchor. Site architecture kept structurally separate from medical dermatology topical authority to avoid dilution.
2. Paid — Google + Meta + LSA where eligible
Google Ads on branded and non-branded cosmetic intent, geo-fenced to ZIP-code catchments each dermatologist actually sees clients from. Local Service Ads where the practice qualifies. Meta Advantage+ campaigns for cosmetic-only intent with HIPAA-scoped audience construction and TCPA-safe lead-form consent language.
3. GBP density — per location, per state
Angryturtle-run GBP for every clinical address, category-optimised for cosmetic dermatology alongside dermatology. Post cadence, review response, Q&A seeding, service catalogue depth, and photo hygiene scoped to state medical board testimonial rules.
4. YouTube dermatologist-authority (YODA)
Long-form dermatologist-authority publishing that positions the practice's cosmetic dermatologists as the citation surface for AI Overviews and PAA panels on cosmetic dermatology queries. Doubles as the pre-consult education library and the manufacturer rewards enrolment funnel.
5. Reputation cross-monitoring including RealSelf
Google, RealSelf, Healthgrades, Vitals, Zocdoc, Yelp (medical listings), Reddit skincare and injectable subreddits. Cosmetic dermatology draws heavier RealSelf and Reddit weight than medical derm; reputation strategy has to account for that. Review-request cadence tied to satisfied-client triggers with state-consent capture.
6. Cosmeceutical commerce + CRM attribution
Where the practice runs a serious cosmeceutical retail line (SkinCeuticals, Alastin, ZO Skin Health, Obagi, EltaMD, Skinbetter), we build the ecommerce SEO overlay and email/SMS retention flows. CRM integration where the practice runs one; call-tracking with HIPAA-scoped recording where they do not. Per-location, per-provider, per-service P&L attribution.
The US cosmetic dermatology buyer journey — where physician credibility earns the click
US cosmetic dermatology buyers move through a journey that is more research-heavy than a med spa buyer and less credentialed-anxiety-driven than a plastic surgery buyer. The physician anchor is what pulls buyers who want an aesthetic result but do not want a med spa experience or an OR appointment. Understanding the specific shape of that journey — and where the marketing changes the conversion — is what separates a plan that fills the dermatologist's cosmetic column from one that just accumulates form fills.
Stage 1 — Trigger and initial research
Cosmetic dermatology buyers enter through a mix of triggers — an aspirational event (wedding, reunion, career transition), a medical dermatology visit where the cosmetic column is introduced by the physician, a social media video demonstrating a specific product or technique, a friend's Botox result, or a GLP-1 weight loss that revealed loose skin or facial volume loss. The buyer often knows the specific product or procedure they are considering before they know which dermatologist they will consult. Marketing has to be findable on both procedure-specific queries and dermatologist-name queries in the metro.
Stage 2 — Physician credibility comparison
This stage is where cosmetic dermatology wins or loses share against med spa alternatives. Buyers compare dermatologist credentials, before/after libraries, RealSelf presence, Instagram feed, and YouTube education content across a shortlist. The comparison window is measured in days for injectables and weeks for higher-ticket laser and body work. Marketing has to make the dermatologist's credentials visible without slipping into superlative claim language that state medical boards prohibit. This is one of the most compliance-tight balancing acts in the whole campaign.
Stage 3 — Consult booking
Cosmetic dermatology consults skew more phone-call-led than med spa consults but less than plastic surgery. A meaningful share of cosmetic dermatology buyers still want a phone conversation before booking, especially for higher-ticket laser and body work. But injectables and cosmeceutical consultation booking has moved substantially online. We build dual-path booking — phone-first for higher-ticket consideration, online-book-first for injectable intent — with HIPAA-scoped analytics on both.
Stage 4 — First visit and treatment planning
Cosmetic dermatology first visits typically convert into a treatment plan rather than a single procedure — the dermatologist sees a face, a body, or a skin regimen and proposes a phased series across neurotoxin, filler, laser and cosmeceuticals. Post-visit is where the plan converts to revenue. Marketing extends into that window with treatment-plan follow-up SMS, education emails on each phase of the plan, and rewards enrolment where applicable.
Stage 5 — Ascension and cosmeceutical retention
Post-first-visit LTV in cosmetic dermatology runs 4× to 8× the initial ticket over 24 months when the practice's post-visit journey introduces buyers to complementary services and prescription cosmeceutical regimens with state-compliant education. Cosmeceutical retention specifically compounds — a prescription cosmeceutical regimen sold at the first visit typically produces 6 to 12 months of recurring revenue and materially higher second-visit conversion. We scope this into the acquisition engagement because acquisition ROI without ascension design is a leaky pipe on any cosmetic derm P&L.
What a US cosmetic dermatology engagement costs — and CPQL to expect per metro
Retainers are custom-scoped per practice against dermatologist count, location count, state footprint, service catalogue breadth, and whether the practice runs a serious cosmeceutical commerce line. There are no packaged tiers because a solo cosmetic dermatologist in Scottsdale does not need the same stack as a five-state cosmetic derm arm of a larger dermatology platform.
Practical retainer ranges by practice profile:
- Solo cosmetic dermatologist, one high-CPC metro location — $2,500 to $4,500/month. SEO + GBP + one paid channel (usually Meta on cosmetic-injectable intent or Google on laser intent), monthly reporting, quarterly cosmetic-column strategy review.
- Two-to-three location cosmetic dermatology practice, single state — $4,500 to $6,500/month. Full SEO stack across cosmetic catalogue and provider clusters, GBP density per location, Google + Meta paid, reputation cross-monitoring, YouTube dermatologist-authority pilot, cosmeceutical retention track.
- Cosmetic dermatology arm of a multi-state dermatology group or PE-backed platform — $6,500 to $8,000+/month. Full stack plus per-location, per-state P&L attribution, per-dermatologist content publishing, national cosmetic SEO across every state, CRM integration for true cost-per-completed-consult and per-cosmeceutical-conversion reporting.
Media spend runs pass-through and is scoped separately, typically $3,500 to $40,000 per month depending on ambition and the number of markets in play. Product SKUs like Angryturtle ($12/month per location for GBP OS) run in parallel where per-location density is the acquisition constraint.
National CPQL benchmarks — cost per cosmetic dermatology consult by metro cohort
Cosmetic dermatology CPQL is priced against a booked consult with the dermatologist — not against a top-of-funnel form fill. The ranges below are mature-campaign benchmarks Ichelon Global operates against across our current US book, not first-90-day exploration numbers.
- Top-CPC metros (Manhattan, Beverly Hills, Miami, Scottsdale). Injectable-intent CPQL typically returns $110 to $220. Laser and body-contouring CPQL runs $180 to $320 because the buyer research window is longer and the trust bar higher.
- Mid-CPC metros (Dallas, Houston, Atlanta, Nashville, Austin, Chicago, Boston). Injectable-intent CPQL typically returns $75 to $150. Laser and body $130 to $240.
- Emerging metros (Charlotte, Raleigh, Denver, Portland, San Antonio, Kansas City, Minneapolis). Injectable-intent CPQL typically returns $60 to $110. Laser and body $100 to $200.
- Cosmeceutical commerce. Where a practice runs a serious cosmeceutical retail line, blended commerce CPA (cost per online cosmeceutical order) runs $18 to $45 in mature campaigns depending on brand mix and average order value.
City-level cosmetic dermatology pages Ichelon Global maintains — the national cluster
This flagship page consolidates the semantic cluster of city-level cosmetic dermatology marketing pages Ichelon Global maintains across the US. Each metro page below carries its own state medical board scoping, its own paid-media CPC calibration, and its own submarket-level demand data. Practices researching us should read the metro page for their own market alongside this national flagship.
Not listed above? We take on new-market engagements every quarter. If your cosmetic dermatology practice operates in a metro that does not have a dedicated Ichelon Global page yet — Chicago, Boston, Seattle, Denver, Minneapolis, San Diego, Philadelphia, Charlotte, Portland, Salt Lake City and dozens more are actively serviced without a dedicated landing page yet — the delivery stack and pricing are identical.
Search Intelligence Trifecta — organic and paid on one national stack
Every US cosmetic dermatology engagement runs on the Search Intelligence Trifecta — Angryturtle, SIE and YODA. Paid acquisition buys the consult today; SIE earns the ranking tomorrow so the same query is free next quarter. YODA builds the dermatologist-authority library that pulls in both patient search and manufacturer-rewards enrolment. Angryturtle keeps every US clinical address dense on Google Maps.
Angryturtle · GBP OS for every US location
Post cadence, review response, Q&A seeding, photo hygiene, service catalogue depth — scoped to each state's testimonial rules. Multi-location cosmetic derm practices get consolidated review monitoring across every clinical address. Solo plan from $12/month per location; agency-managed plans priced separately.
SIE · Search Intelligence Engine
Topic map, entity graph and internal-link engineering around US cosmetic dermatology query patterns — cosmetic catalogue level, dermatologist-provider level, cosmeceutical brand level. Content briefs optimised for AI Overview citation and PAA answer boxes on cosmetic intent across state, metro and neighbourhood queries.
YODA · YouTube AIO for cosmetic derm
Dermatologist-authority builds — treatment explainers, technique walkthroughs, before/after case discussion with state-board-compliant framing. Optimised for AI Overview citation and YouTube's recommendation engine. Doubles as the pre-consult education library and cosmeceutical regimen education resource.
US cosmetic dermatology marketing — national-scope questions
How do you separate cosmetic dermatology marketing from medical dermatology on the same practice?
We build two topic maps under one delivery engagement. Medical dermatology sits on its own site architecture (educational-first, insurance-verified, referral-tuned, medical condition-led URLs). Cosmetic dermatology sits on structurally separate architecture (aspirational-first, cash-pay, social-driven, procedure and product-led URLs). Depending on the practice, that separation can be sitewide URL structure, a subdomain, or a satellite site. Splitting them avoids conflicting internal-link priorities, competing site architecture, and duplicated GBP effort, and lets each cluster earn its own topical authority under Google's core update posture.
What is the CPQL range for cosmetic dermatology consults across US metros?
Injectable-intent CPQL runs $60 to $110 in emerging metros, $75 to $150 in mid-CPC metros (Dallas, Houston, Atlanta, Nashville, Austin), and $110 to $220 in top-CPC metros (Manhattan, Beverly Hills, Miami, Scottsdale). Laser and body-contouring CPQLs run roughly 1.5× to 2× the injectable band within the same metro tier because buyer research windows are longer and trust bars higher.
Do you build cosmeceutical ecommerce into the cosmetic dermatology engagement?
Yes, where the practice runs a serious cosmeceutical retail line (SkinCeuticals, Alastin, ZO Skin Health, Obagi, EltaMD, Skinbetter and similar). We build ecommerce SEO overlay on the medical site, email and SMS retention flows scoped for CAN-SPAM and TCPA compliance, and product-level content that pulls buyer intent into either an online order or an in-office visit. Blended commerce CPA runs $18 to $45 in mature campaigns.
Can you integrate with Allergan Alle, Galderma ASPIRE Rewards and Merz Xperience+ for our cosmetic dermatology practice?
Yes. Manufacturer rewards enrolment is one of the highest-ROI additions to a cosmetic derm acquisition engagement. We build enrolment landing pages, first-visit handoff flows, and post-visit SMS reminders that route eligible buyers into the correct rewards program without breaking FTC endorsement or FDA fair-balance rules. This typically lifts second-visit conversion by 15 to 30 percent in accounts that were not previously running rewards tightly.
How does the RealSelf, Reddit and Instagram reputation surface differ for cosmetic derm versus med spa?
Cosmetic dermatology draws heavier RealSelf and Reddit weight than med spa because buyers are researching a specific dermatologist as the authority, not a general aesthetic experience. RealSelf reviewer profiles carry disproportionate weight on injectable and laser queries; Reddit skincare and injectable subreddits (r/SkincareAddiction, r/30PlusSkinCare, r/Botox) carry disproportionate weight on cosmeceutical and product-specific research. We build the reputation strategy around all three surfaces, not just Google reviews.
Do you serve US cosmetic dermatology practices outside Texas, California, Florida and New York?
Yes. We currently run engagements across Georgia, Arizona, Tennessee, Illinois, Washington, Colorado, North Carolina, Massachusetts and other states, and we scope net-new engagements in any state where a licensed dermatologist can advertise cosmetic services. The delivery stack and pricing are identical to metros with dedicated landing pages.
How do you handle Meta Ads Personal Attributes rejections on cosmetic dermatology creative?
Meta rejects cosmetic derm creative that implies knowledge of a person's appearance, skin condition or health status — even when the creative is technically compliant with FTC and state medical board rules. We rewrite creative pre-flight against the current Meta policy interpretation, monitor account-level policy risk continuously, and structure campaigns to reduce the surface area for cascading account restrictions. Rejections are appealed through official Meta channels rather than resubmitted under a different account.
How does the Dallas HQ actually work for a practice on the other side of the country?
Dallas is where our US delivery pod sits — leadership, senior strategy, creative direction and reporting. Central time zone gives us working overlap with every US metro. Client calls happen on Google Meet or Zoom; reporting is asynchronous and on-demand; senior team travel to on-site strategy sessions is scoped where the engagement warrants it. Practices in California, Florida, New York and every other state get the same senior attention as DFW practices — the physical office is the compliance and delivery anchor, not a limitation on geography.
Scope your US cosmetic dermatology marketing engagement
Book a 30-minute scoping call with a member of the Leadership Team, email Santosh (Dallas HQ) directly, or WhatsApp us. Central time zone hours, same day where we can.
Adjacent US aesthetic and cosmetic pillar pages
Healthcare brands ICG
has worked with.
A representative slice of the 300+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.
